Eprociclovir
Eprociclovir is an antiviral drug with nucleoside analogues. The triphosphate form of Eprociclovir is converted into the active form within virus-infected cells by the virus and possible cellular enzymes, including the viral thymidine kinase, thereby inhibiting the activity of the viral DNA polymerase. The primary activity of Eprociclovir is against herpes viruses, including but not limited to cytomegalovirus (CMV) and herpes simplex virus (HSV). Eprociclovir can be used in studies interfered with by sensitive viruses.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 145512-85-2
- Formule: C11H15N5O3
- Masse moléculaire:265.27
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Voir tous les produits spécifiques à Isoform DNA/RNA Synthesis
More
Activité biologique
|
DNA Polymerase |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| CCRF-CEM | IC50 |
>100 μg/mL
Compound: 3a
|
Inhibitory activity against 1RF strain of HIV-1 by plaque reduction assay in CEM cells
Inhibitory activity against 1RF strain of HIV-1 by plaque reduction assay in CEM cells
|
[PMID: 9548818] |
| HEL | IC50 |
0.67 μg/mL
Compound: 1
|
Tested for inhibitory activity against Varicella zoster virus(VZV) by plaque reduction assay using HEL cells
Tested for inhibitory activity against Varicella zoster virus(VZV) by plaque reduction assay using HEL cells
|
[PMID: 10649983] |
| HEL | IC50 |
0.67 μg/mL
Compound: 1
|
Tested for Antiherpetic activity against VZV from Kawaguchi strain in HEL cell lines.
Tested for Antiherpetic activity against VZV from Kawaguchi strain in HEL cell lines.
|
[PMID: 10649983] |
| HFF | IC50 |
0.2 μg/mL
Compound: 3a
|
Inhibitory activity against DM625 strain of zoster virus(VZV) by plaque reduction assay in HFF cells
Inhibitory activity against DM625 strain of zoster virus(VZV) by plaque reduction assay in HFF cells
|
[PMID: 9548818] |
| MRC5 | IC50 |
0.0093 μg/mL
Compound: 1
|
Tested for Antiherpetic activity against HSV-1 from Tomioka strain in MRC-5 cell lines.
Tested for Antiherpetic activity against HSV-1 from Tomioka strain in MRC-5 cell lines.
|
[PMID: 10649983] |
| MRC5 | IC50 |
0.12 μg/mL
Compound: 1
|
Tested for Antiherpetic activity against HSV-2 from 186 strain in MRC-5 cell lines.
Tested for Antiherpetic activity against HSV-2 from 186 strain in MRC-5 cell lines.
|
[PMID: 10649983] |
| MRC5 | IC50 |
0.21 μg/mL
Compound: 1
|
Tested for Antiherpetic activity against VZV from clinical isolates of MRC-5 cell lines.(average of six isolates)
Tested for Antiherpetic activity against VZV from clinical isolates of MRC-5 cell lines.(average of six isolates)
|
[PMID: 10649983] |
| Vero | CC50 |
240 μg/mL
Compound: 1
|
Tested for cytotoxicity in vero cells, activity is expressed as CC50.
Tested for cytotoxicity in vero cells, activity is expressed as CC50.
|
[PMID: 10649983] |
| Vero | CC50 |
240 μg/mL
Compound: 3a
|
Cytotoxic concentration to uninfected vero cells
Cytotoxic concentration to uninfected vero cells
|
[PMID: 9548818] |
| Vero | IC50 |
0.02 μg/mL
Compound: 3a
|
Inhibition of Tomioka strain of herpes simplex virus( Tomioka strain of HSV-1) by quantitative CPE reduction assay in vero cells
Inhibition of Tomioka strain of herpes simplex virus( Tomioka strain of HSV-1) by quantitative CPE reduction assay in vero cells
|
[PMID: 9548818] |
Chemical Information
-
CAS No. 145512-85-2
-
Masse moléculaire 265.27
-
Formule C11H15N5O3
-
SMILES
OC[C@@]1([C@@H](C1)CO)CN2C3=C(C(N=C(N3)N)=O)N=C2
-
Synonyms
A-5021
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)